{"name":"ModeX Therapeutics, An OPKO Health Company","slug":"modex-therapeutics-an-opko-health-company","ticker":"","exchange":"","domain":"modexanopkohealthcompany.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5zUEZ3OGtHdkZncF80NkZIOXVlTFNSVFlqNFJqNEZfMWdSd1FPcGNOcElCU2hMd05MWVBZSF9uTnhCWWlkWXNkNEVqUk1GS2g5d0c0anRKNXU4amFjY29uaUdVS3dLWnVPWll0dmprSjVIT3RlQkZvR0JXQQ?oc=5","date":"2025-10-30","type":"deal","source":"Yahoo Finance","summary":"Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals - Yahoo Finance","headline":"Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNdnF6MHFGNk1qWFc2TFZtVUNkMmJPRHM0ZG9LSFBINXY3VnBwNURnQzVENlVaRTdqVy1LdVpxS0NBQWZ6UURqbGJuRzVYUUxVV1d6LTlZNEZKWFNzbDNWaGJFWGNSR1NMRkRrNlAwQnNUMzZ5QlktMWx1YlU5NUdUV0p0MzJBSnVxZ3ZSUFk4ZEt6MXczYmMxMGJKbjAwM3h4SWVlRnE4WXhra2o2S1hVbDZFUDI?oc=5","date":"2025-10-30","type":"deal","source":"The Pharma Letter","summary":"Regeneron partners with ModeX to advance multispecific antibody drugs - The Pharma Letter","headline":"Regeneron partners with ModeX to advance multispecific antibody drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAJBVV95cUxPcUpudmVYRG5YNEd0VW5IVUROZWVKcG9sVEtHbnR1LWxaQ1VGNUYxVVB2Mm1IeFRnN0xmT01yV29XbWdvb1AtbHBxM0hhcldSTC1uOHE0ZTMxN0hPZHcwZHI2QTNDQVZGd2xlZGZuRDdyTXY3RzRGSnVsOVc1MTV4bmhDR1ZTRWoyNmoxM1VqQ253dmh3em40a0pwM3J0LV9RdFRGZFlTbWVWNERRQVhTdnFkWjRGR3Z2QW9vY2ZMMVY0NHBXZFdqaXdQRHFYcWllSlF1YjREcnpfUlh2MjhrS3k4U1VMWk8xOU91Q19LM1FjbEpnX244SDhRYThTTG5MWGt2REhpRks0UlkwTEQtVkwzNDVCak9BUkNXVDg1d09JS0lweUV3bjNscUFKemt5dVdjeEFnUGd4MVRieGFYengwTmFtbGUz?oc=5","date":"2025-10-29","type":"pipeline","source":"GlobeNewswire","summary":"OPKO Health’s ModeX Therapeutics Enters into Research - GlobeNewswire","headline":"OPKO Health’s ModeX Therapeutics Enters into Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPX1Mta3dKRWoyb1JZVk1pcURiVFhDd3JlMElYclRkMGY4YXF6bGJVQmE3V3E4cm5lZjZLWTlvZ0IzSmRMR2UwNFQ5bkdYNGdWTTN4Wmp3NjA5XzE4aFRYN21qcEhPdENyajl2N2RMTTUzV3M2a0k0dTVxcTZ3eHlOTHhHUE1MQXNReUd2N3E1V096dlFUOTBCcFoyem9JYkpxTlpNb2pR?oc=5","date":"2025-10-29","type":"pipeline","source":"Fierce Biotech","summary":"Regeneron pledges more than $1B biobucks for ModeX multispecific antibodies - Fierce Biotech","headline":"Regeneron pledges more than $1B biobucks for ModeX multispecific antibodies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBMdm9IMm81N3N1UmpOdUZCYmVJV3J6dTliMVU3Qm1ZYWcyWG9rQkhoSEZYSUNqQnl0RmJNYWJHbEZ5dzdlZF9iVHRsZnY1U2ZHUldZ?oc=5","date":"2025-10-29","type":"deal","source":"FirstWord Pharma","summary":"Regeneron inks multispecific deal with ModeX worth more than $1B - FirstWord Pharma","headline":"Regeneron inks multispecific deal with ModeX worth more than $1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQYWhmcVJqdUlXWjJfQmJpMFRZNzJlbTFjSWNsWHlndVpzSVF6Y2RUQ2M1NGhqdi02UkVHYnZmVXFIalNDWHg1VktWZ3pVY19ybmxERzUySzREcUZrcDB5UG4zallzdlZWMlI0MVZkRElkR0RQSmJTWVhwNmxkSjh0emRiWmJ2aFlyeWdJMzBJQjVRX250dHY4THFrc1BTcDc2MDFz?oc=5","date":"2025-03-03","type":"pipeline","source":"OPKO Health, Inc.","summary":"EXHIBIT 21.0 SUBSIDIARIES OF OPKO HEALTH, INC. - OPKO Health, Inc.","headline":"EXHIBIT 21.0 SUBSIDIARIES OF OPKO HEALTH, INC. - OPKO Health, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQcmljak91aHFEMHdNV2VUNF9zT2Z5YlZOZXdoeFBhRGc2QWh1TXVYZUNnR1BHeTRob2hETjJ1Tll0dXYycFdvUE5qTFg0ekg4U3dXdHFpeGtsb3RKVHNlZnd0VFNQc2wtRV9JSVh1WFlzRDZVNTBCRE9OblI2TVhUUlZEMHNNM0NzOVdYVkhBd0Y5X2VtWjNibHkyZkFOU3hvdXhWWHZjVFR1aWZyRVNrbnY3eW5RM1RQT0JvTzBVUW05cTNkV213aklSTFpDdGx0dU1WQ0JWTzlyZUNxdl9Ld3BiWmU?oc=5","date":"2025-02-27","type":"earnings","source":"OPKO Health, Inc.","summary":"OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results - OPKO Health, Inc.","headline":"OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results - OPKO Health, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPaFJONkc1d0FRTFREV1hhTmtTaGhXX1ZPeGx4TVdUVEpkNGhhVVNJck5ZZTlhSzBZeExxQ1FCREhoNDVocUlzOWxJb1hHbTZEMTQ3M1d3Q3NQc01mU25kbHV1TlVJVHh1SlV6c3hndHNvMERjX1pKZ3hDZUd4clpzbWJ1UzFuLWhia3pEcjlNV0NkamhlZFFyR1RIVXpZT1NfZkQ5TGJ4NkNnTFpGU1oyT3g3NVZjZExqNDhXZDRQSHVleFFWRHpjOHBnd1B0ajVVcWtPZEpn?oc=5","date":"2023-03-08","type":"deal","source":"Reuters","summary":"Opko Health shares rise on Merck deal for experimental Epstein-Barr vaccine - Reuters","headline":"Opko Health shares rise on Merck deal for experimental Epstein-Barr vaccine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPZHNvM3luTFlxcmd0UjJIQTRCY21JaW1zeUVpajQ0OURNQ054NVNQMFlpWkJBY0IzMDh1dTBzckR2LU5FTTZVdFhONktFbHQ0WTkyS2lzcEJCTGJ4cVpYeGhnQkY4NWRKS2JsX25IbmhEamdUOUFjM2FPalk3eHE3Rk8yQnlyaGc?oc=5","date":"2023-03-08","type":"deal","source":"pharmaphorum","summary":"Merck sets sights on Epstein-Barr virus jab with Opko deal - pharmaphorum","headline":"Merck sets sights on Epstein-Barr virus jab with Opko deal","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}